Literature DB >> 16531978

The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases.

Y Fujii1, J Khoshnoodi, H Takenaka, M Hosoyamada, A Nakajo, F Bessho, A Kudo, S Takahashi, Y Arimura, A Yamada, T Nagasawa, V Ruotsalainen, K Tryggvason, A S Lee, K Yan.   

Abstract

The mechanism by which glucocorticoids govern antiproteinuric effect in nephrotic syndrome remains unknown. Present study examined the protective role of dexamethasone (DEX) in the intracellular trafficking of nephrin under endoplasmic reticulum (ER) stress. Human embryonic kidney-293 cell line expressing a full-length human nephrin was cultured in mediums containing 5.5 or 25 mM glucose with or without DEX. The result revealed that glucose starvation evoked a rapid ER stress leading to formation of underglycosylated nephrin that was remained in the ER as a complex with calreticulin/calnexin. DEX rescued this interfered trafficking through binding to its receptor and stimulating the mitochondrial transcripts and adenosine 5' triphosphate (ATP) production, leading to synthesis of fully glycosylated nephrin. These results suggest that ER-stress in podocytes may cause alteration of nephrin N-glycosylation, which may be an underlying factor in the pathomechanism of the proteinuria in nephrotic syndrome. DEX may restore this imbalance by stimulating expression of mitochondrial genes, resulted in the production of ATP that is essential factor for proper folding machinery aided by the ER chaperones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531978     DOI: 10.1038/sj.ki.5000317

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

Review 1.  Endoplasmic reticulum stress in the kidney.

Authors:  Masanori Kitamura
Journal:  Clin Exp Nephrol       Date:  2008-06-07       Impact factor: 2.801

2.  TM4SF10 and ADAP interaction in podocytes: role in Fyn activity and nephrin phosphorylation.

Authors:  Timur A Azhibekov; Zhenzhen Wu; Aparna Padiyar; Leslie A Bruggeman; Jeffrey S Simske
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-31       Impact factor: 4.249

Review 3.  Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?

Authors:  Aowen Zhuang; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

4.  Dosing of glucocorticosteroids in nephrotic syndrome.

Authors:  Otto Mehls; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2011-09-09       Impact factor: 3.714

Review 5.  Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Authors:  Jurgen Heymann; Cheryl A Winkler; Maarten Hoek; Katalin Susztak; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

Review 6.  From Glomerular Endothelium to Podocyte Pathobiology in Preeclampsia: a Paradigm Shift.

Authors:  Rosanne J Turner; Kitty W M Bloemenkamp; Marlies E Penning; Jan Anthonie Bruijn; Hans J Baelde
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

7.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

8.  Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome.

Authors:  Grzegorz Zalewski; Anna Wasilewska; Walentyna Zoch-Zwierz; Lech Chyczewski
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

9.  Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.

Authors:  Jiong Zhang; Jeffrey W Pippin; Ronald D Krofft; Shokichi Naito; Zhi-Hong Liu; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-13

Review 10.  The podocyte as a direct target for treatment of glomerular disease?

Authors:  Sandeep K Mallipattu; John C He
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.